Cleared Traditional

K951749 - BIO-LIPID LIPID CONTROL- LEVEL 1

K951749 is the FDA 510(k) clearance for BIO-LIPID LIPID CONTROL- LEVEL 1 by Biocell Laboratories, Inc.. It is a Class 1 Chemistry device (product code JJY) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1995
Decision
28d
Days
Class 1
Risk

K951749 is an FDA 510(k) clearance for the BIO-LIPID LIPID CONTROL- LEVEL 1,2 AND 3. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Biocell Laboratories, Inc. (Rancho Dominguez, US). The FDA issued a Cleared decision on May 15, 1995 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biocell Laboratories, Inc. devices

Submission Details

510(k) Number K951749 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 1995
Decision Date May 15, 1995
Days to Decision 28 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 88d · This submission: 28d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 477
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K951749.
CSF LIQUID CEREBROSPINAL FLUID CONTROL
K952877 · Medical Analysis Systems, Inc. · Aug 1995
PROSTAT CONTROL
K943394 · Quantimetrix Corp. · May 1995
LIQUICHEK(TM IMMUNOLOGY CONTROL, LEVELS 1.2. AND 3
K945651 · Bio-Rad · May 1995
VIGIL MULTICHEK CONTROLS
K951170 · Beckman Instruments, Inc. · Apr 1995
DOCUMENT SERUM MULTIANALYTE CALIBRATION VERIFICATION TEST SET
K950469 · Casco Standards · Apr 1995
LIQUID ASSAYED TUMOR MARKER CONTROL LEVEL 1, LEVEL 2, LEVEL 3
K944525 · Medical Analysis Systems, Inc. · Mar 1995